21 results
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
commonly used drugs ... for tuberculosis ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
Antituberculosis Drugs ... IDSA First-line drugs ... Moxifloxacin #Tuberculosis ... #management #pharmacology ... #Table
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the ... Treatment of COVID-19 Infection ... smfarmhosp_smfh #Drugs ... Treatment #COVID19 #Pharmacology ... #Table #Management
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies in critical ... steroids to treat infectious ... meningitis - Tuberculous ... #Pharmacology # ... Management #Treatment
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
Differential Diagnosis Algorithm ... • Malignancy Infectious ... Endocarditis • Tuberculosis ... Myasthenia Gravis Pharmacologic ... Differential #Diagnosis #Algorithm
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infections/year ... for 4.6% of new infections ... drug use • Silicosis ... characteristic features Clinical ... TB #Diagnosis #Management
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... Treatment of COVID-19 Infection ... highlighted circle= clinical ... Treatment #COVID19 #Pharmacology ... #Table #Management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Resistant Tuberculosis ... are contacts of infectious ... #MDRTB #management ... antimicrobials #regimens #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infections/year ... for 4.6% of new infections ... drug use • Silicosis ... characteristic features Clinical ... TB #Diagnosis #Management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... #medications #table